CREB1 and neoplasm: Together, our results indicated that HLSC-EVs and TKIs have a synergistic anti-tumor effect on renal CSCs inducing an enhancement of apoptosis by a combined effect on Akt/mTOR, Erk and Creb intracellular pathways, known to be pivotal in the induction of tumor growth and survival.